SELLAS Life Sciences Group, Inc. Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount
SELLAS Life Sciences Group, Inc. (SLS) reported Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount of $100.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-23.
Discontinued › Notes
us-gaap:WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount · last filed 2021-03-23
- SELLAS Life Sciences Group, Inc. warrant, down round feature, (increase) decrease in equity, amount for fiscal 2020 was $100.00K.
| Period end | Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount 12 month |
|---|---|
| 2020-12-31 | $100.00K 10-K · filed 2021-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |